Combination Chemotherapy with Cyclophosphamide, Vincristine, Cisplatin and Etoposide(COPE) Combined with Radiotherapy for Small Cell Lung Cancer
Main Authors: | Nam, Yong Jin, Choi, Chul Weon, Shin, Sang Won, In, Kwang Ho, Kang, Kyung Ho, Kim, Jun Suk, Choi, Young Ho, Kim, Chul Yong, Choi, Myung Sun |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Association of Internal Medicine
1995
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532031/ |
Similar Items
-
Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood.
by: Shimizu, E., et al.
Published: (1993) -
Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells.
by: Souès, S., et al.
Published: (1995) -
Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide
by: Choi, Aery, et al.
Published: (2016) -
Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing’s and other Small Round Cell Sarcomas
by: Whelan, Jeremy, et al.
Published: (2012) -
Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
by: Lewin, Jeremy, et al.
Published: (2013)